Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Innovative Trials named a finalist at the PME Award

    Press Releases | October 21, 2024 | Innovative Trials

    Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.

    Sex, Gender, and the Brain: The Women’s Brain Foundation and Medscape Education Announce Groundbreaking Learning Centre

    Press Releases | October 18, 2024 | Medscape Education

    LONDON--(BUSINESS WIRE)--The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and healthcare since 2017; and Medscape...

    AMICULUM earns EcoVadis silver award for second consecutive year

    Press Releases | October 17, 2024 | Amiculum

    We are proud to announce that AMICULUM has achieved the silver award from EcoVadis, a global leader in sustainability assessments, for the second year running! Scoring 73 out of 100,...

    Cultivating Interest in Infectious Disease Education at ID Week 2024

    Press Releases | October 15, 2024 | Medscape Education

    IDWeek starts tomorrow, October 16, and Medscape is bringing outcomes and education! We are excited to announce Medscape is presenting six posters that highlight the significant impact of our educational...

    Innovative Trials appoints new Leadership Team member

    Press Releases | October 15, 2024 | Innovative Trials

    Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

    Mtech Access are exhibiting at ISPOR in Europe

    Press Releases | October 15, 2024 | Petauri Evidence

    • Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

    TOMORROW: Last chance to register for FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

    Press Releases | October 14, 2024 | Origins – The Patient Focused Specialists

    Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   Wendy Erler and Alfred Samuels are ready to join Su Smith and...

    Behavioural Data Offering from Medscape Global

    Press Releases | October 9, 2024 | Medscape Medical Affairs

    See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and content...

    FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

    Press Releases | October 8, 2024 | Origins – The Patient Focused Specialists

    Only one week to go until our highly anticipated webinar: “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   We’re thrilled to have Wendy Erler and Alfred Samuels joining...

    Navigating US payer evidence needs to optimise market access

    Videos and Podcasts | October 8, 2024 | Petauri Evidence

    What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...